VEGFA and neoplasm: In SGC-7901 cells, AS-IV [133] suppresses cell growth by decreasing the activity of cyclooxygenase-2, resulting in the reduction of prostaglandin E2 production and the downregulation of VEGF, ultimately leading to a decrease in tumor growth.